Millennium Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $169K | Buy |
|
|||||
|
2024
Q1 | $61.7K | Sell |
|
|||||
|
2023
Q4 | $63.2K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.1M | Buy |
|
|||||
|
2022
Q4 | $467K | Sell |
|
|||||
|
2022
Q3 | $572K | Sell |
|
|||||
|
2022
Q2 | $1.61M | Buy |
|
|||||
|
2022
Q1 | $275K | Sell |
|
|||||
|
2021
Q4 | $816K | Buy |
|
|||||
|
2021
Q3 | $49K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.35M | Buy |
|
|||||
|
2020
Q4 | $624K | Sell |
|
|||||
|
2020
Q3 | $335 | Buy |
|
|||||
|
2020
Q2 | $12K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $60K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $17K | Sell |
|
|||||
|
2018
Q3 | $53K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $305K | Sell |
|
|||||
|
2017
Q4 | $324K | Buy |
|
|||||
|
2017
Q3 | $41K | Sell |
|
|||||
|
2017
Q2 | $216K | Sell |
|
|||||
|
2017
Q1 | $627K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $229K | Buy |
|
|||||
|
2014
Q3 | – | Sell |
|
|||||
|
2014
Q2 | $53K | Buy |
|